The antitumor compound triazoloacridinone C-1305 inhibits FLT3 kinase activity and potentiates apoptosis in mutant FLT3-ITD leukemia cells

Ewa Augustin(Gdańsk University of Technology), Barbara Borowa‐Mazgaj(National Center for Toxicological Research)
Acta Pharmacologica Sinica
February 2, 2015
Cited by 6


Related Papers